We are live on ! Find out more
LSBPW

LakeShore Biopharma Warrants
LSBPW

Delisted

LSBPW was delisted on the 19th of September, 2025.

Back to rankings

Fund managers haven’t disclosed any holdings of LSBPW yet.

LSBPW Hedge Fund Activity: Q1 2026 in Review

2 of the 8,128 institutional investors tracked by Wall St. Rank reported a position in LakeShore Biopharma Warrants (LSBPW) for Q1 2026, worth a combined $18 — down 64% from $50 a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of LSBPW and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was HGC Investment Management, exiting entirely with an estimated $35 sold.

  • 2 institutional investors held LakeShore Biopharma Warrants (LSBPW) as of Q1 2026, down from 3 in Q4 2025.
  • Funds reported $18 of LakeShore Biopharma Warrants stock for Q1 2026, down 64% quarter-over-quarter.
  • 0 funds opened new LakeShore Biopharma Warrants positions in Q1 2026 and 1 closed out, a net change of -1 holder.
  • The largest LakeShore Biopharma Warrants seller in Q1 2026 was HGC Investment Management, an estimated $35 sold.

Based on aggregated 13F filings for Q1 2026.